Le

Leukemia

Leukemia is a leading journal covering all aspects of the research and treatment of leukemia and allied diseases.

Looking to publish in Leukemia? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Hematology, Oncology
Impact Factor 13.4
Quartile Q1
Open Access Type Hybrid
ISSN 0887-6924
eISSN 1476-5551
Invitation Only No
Cost Range Full Article / Review: £3790.00/$5390.00/€4390.00; Letter / Correspondence / Perspective: £2,150.00/$3,235.00/€2,635.00

Submission Instructions

Leukemia accepts the following article types. Click on an article type to view submission instructions.

Article

Cover Letter A cover letter is required. Cover letter must provide the corresponding author’s affiliation and contact information, briefly explain the importance of the work and its suitability for the journal readership, and confirm that the manuscript reports original research that has not been previously published or submitted elsewhere.
Abstract An abstract is required. Abstract must not exceed 200 words. Abstract must be unstructured.
Manuscript Main text must not exceed 4,000 words, excluding the abstract, tables/figures, and references. Manuscript should include a Methods section with enough detail for reproduction and a Discussion whose final paragraph states the main conclusions and future research direction. Manuscript must document any use of a large language model in the Methods section or another suitable section, include an author contributions statement, include competing interests information, and be indexed with one to four unique subject terms.
References References are limited to a maximum of 60. References must follow Vancouver format. In-text citations must be numbered consecutively from 1 and the reference list must be in numerical order, listing all authors up to six and the first six followed by et al. for more than six.
Figures & Tables Articles may include a maximum of 8 tables or figures. Figures must be uploaded as separate files rather than embedded in the text, and each table must be uploaded as a separate file. Figure legends must be provided on a separate manuscript page after the references, and tables must be editable.
Reformat to Leukemia using Livewrite Premium

Review Article

Cover Letter A cover letter is required. Cover letter must include the corresponding author's affiliation and contact information, briefly explain the importance of the work and its suitability for the journal readership, and confirm that the submission is original, unpublished, and not under consideration elsewhere.
Abstract An abstract is required. Abstract must be unstructured and must not exceed 300 words. Abstract must be unstructured.
Manuscript Main text must not exceed 6,000 words, excluding the abstract, tables/figures, and references. Use of a large language model must be documented in the Methods section or in a suitable alternative part of the manuscript if no Methods section is available.
References Review Articles may include a maximum of 100 references. References must follow Vancouver format. References must be cited in the text as numbered citations starting at one and listed in double-spaced numerical order, listing all authors for up to six authors and the first six followed by et al. for more than six authors.
Figures & Tables Review Articles may include a maximum of 8 tables or figures. Figures must be uploaded as separate files and must not be embedded within the text, and each table must be uploaded as a separate file. Composite figures containing more than three individual figures count as two figures.
Reformat to Leukemia using Livewrite Premium

Full Article

Cover Letter A cover letter is required. Cover letter must include the corresponding author's affiliation and contact information, explain the importance of the work and its suitability for the journal readership, and confirm that the material is original research that has not been previously published or submitted elsewhere while under consideration.
Abstract Abstract requirements are not specified.
Manuscript Manuscript should include Methods, Results, Discussion, Acknowledgements, author contribution statement, and competing interests information, with the final paragraph of the Discussion highlighting the main conclusions and future research direction. Use of a large language model must be documented in the Methods section or another suitable part of the manuscript if no Methods section is available, and the submission must be indexed with one to four unique subject terms.
References References must follow Vancouver format. In-text citations must be numbered consecutively from 1, references must be listed in numerical order of citation, papers with up to six authors must list all authors, and papers with more than six authors must list the first six followed by et al.
Figures & Tables Composite figures containing more than three individual figures count as two figures. Figures must be uploaded as separate files rather than embedded in the text, and each table must be uploaded as a separate editable file. Figure legends must be provided on a separate manuscript page after the References section, and tables must be editable and clearly labelled sequentially with a title or caption.
Reformat to Leukemia using Livewrite Premium

Letter

Cover Letter A cover letter is required. Cover letter must include the corresponding author's affiliation and contact information, briefly explain the importance of the work and its suitability for the journal readership, and confirm that the material is original research, unpublished, and not under consideration elsewhere.
Abstract Letters do not require an abstract.
Manuscript Letter main text must not exceed 1,500 words, excluding the abstract, tables or figures, and references. Use of a large language model must be documented in the Methods section or in a suitable alternative part of the manuscript if no Methods section is available.
References Letters may include a maximum of 15 references. References must follow Vancouver format. In-text references must be numbered consecutively from 1 and the reference list must be double-spaced in numerical order, listing all authors for up to six authors and the first six followed by et al. for more than six.
Figures & Tables Letters may include a maximum of 2 tables or figures. Figures must be uploaded as separate files and must not be embedded within the text, and each table must be uploaded as a separate file. Tables must be editable and clearly labelled sequentially, and figure legends must be brief, specific, and provided on a separate manuscript page after the references.
Reformat to Leukemia using Livewrite Premium

Correspondence

Cover Letter A cover letter is required. Cover letter must provide the corresponding author's affiliation and contact information, briefly explain the importance of the work and its relevance to the journal readership, and confirm that the submission is original, unpublished, and not under consideration elsewhere.
Abstract Abstract is not required for Correspondence.
Manuscript Main text must not exceed 1,000 words, excluding tables or figures and references. Use of a large language model must be documented in the Methods section or in another suitable part of the manuscript if no Methods section is available.
References References are limited to a maximum of 10. References must follow Vancouver format. In-text citations must be numbered consecutively from 1 and the reference list must be double-spaced in numerical order, listing all authors for up to six authors and the first six followed by et al. for more than six authors.
Figures & Tables A maximum of 2 tables or figures may be included. Figures must be uploaded as separate files and must not be embedded within the text, and each table must be uploaded as a separate file. Figure legends must appear on a separate manuscript page after the references, and tables must be editable.
Reformat to Leukemia using Livewrite Premium

Recent Publications

Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study

S. Rinaldetti, M. Chepeleva, A. Hedblom, C. Sticht, M. Muciek, P. Panayiotidis, J. Richter, U. Olsson-Strömberg, D. Nowak, V. Nowak, P. Ljungman, N. von Bubnoff, K. Lotfi, L. Stenke, T. H. Brümmendorf, H. Hjorth-Hansen, T. Gedde-Dahl, W. Majeed, A. Burchert, P. V. Nazarov, E. Felde, I. Tarnopolscaia, C. Hoelting, A. Fabarius, W.-K. Hofmann, F.-X. Mahon, S. Saussele, M. Pfirrmann

10.1038/s41375-026-03001-5
View Publication

Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity

S. Corradini, M. Maksimos, F. Azab, S. Arsalani, E. Nwarunma, G. Watt, R. Soutar, M. Powell, R. Henderson, J. Travers, Z. Chen, S. Wang, A. K. Azab, M. T. S. Williams

10.1038/s41375-026-03004-2
View Publication

Can natural killer cells cure leukemia?

Frank Cichocki, Martin Felices, Anders W. Matson, Madeline J. Lee, Jeffrey S. Miller

10.1038/s41375-026-02992-5
View Publication

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study

Simon Renders, Maud Ngoya, Laurence de Leval, Herve Finel, Irma Khvedelidze, Rachael Pocock, Ron Ram, Tobias Gedde-Dahl, Yasmina Serroukh, Gesine Bug, Nicolaus Kröger, Arnon Nagler, Thomas Pabst, Werner Rabitsch, Ibrahim Yakoub-Agha, Matthias Eder, Siret Ratip, Christoph Scheid, Jose Antonio Pérez-Simón, Eva Maria Wagner-Drouet, Anna Sureda, Norbert Schmitz, Bertram Glass, Ali Bazarbachi, Peter Dreger

10.1038/s41375-026-02993-4
View Publication

Response kinetics as a dynamic prognostic marker in patients with multiple myeloma

Hee Jeong Cho, Myung-Won Lee, Jae Hoon Lee, Hyeon-Seok Eom, Jongheon Jung, Ho-Young Yhim, Dok Hyun Yoon, Hyungwoo Cho, Sung-Soo Yoon, Ja Min Byun, Young Rok Do, Hyo Jung Kim, Ji Hyun Lee, Sung-Nam Lim, Hye Jin Kang, Ho Sup Lee, Yundeok Kim, Hee Jeong Lee, Sang Min Lee, Kihyun Kim, Joon Ho Moon

10.1038/s41375-026-03007-z
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first editorial decision (median days): 3; Submission to acceptance (median days): 110

Reformat to Leukemia using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should include the affiliation and contact information for the corresponding author, explain the importance of the work and its suitability for the journal readership, confirm the work is original, not previously published, and not under consideration elsewhere, and include previous reviewer comments if the manuscript was previously considered by another journal.

Reformat to Leukemia using Livewrite Premium

What are the publication costs?

Open access APCs are required for open access publication. Full Article / Review: £3790.00/$5390.00/€4390.00; Letter / Correspondence / Perspective: £2,150.00/$3,235.00/€2,635.00. The APC price is determined from the date on which the article is accepted for publication.

Reformat to Leukemia using Livewrite Premium

Research Topics

Acute Myeloid Leukemia Research Chronic Lymphocytic Leukemia Research Chronic Myeloid Leukemia Treatments Acute Lymphoblastic Leukemia research Lymphoma Diagnosis and Treatment Myeloproliferative Neoplasms: Diagnosis and Treatment Multiple Myeloma Research and Treatments Hematopoietic Stem Cell Transplantation Immune Cell Function and Interaction Protein Degradation and Inhibitors Eosinophilic Disorders and Syndromes Retinoids in leukemia and cellular processes CAR-T cell therapy research Epigenetics and DNA Methylation Immunodeficiency and Autoimmune Disorders Histone Deacetylase Inhibitors Research Viral-associated cancers and disorders T-cell and B-cell Immunology Ubiquitin and proteasome pathways Immunotherapy and Immune Responses Childhood Cancer Survivors' Quality of Life Cancer Genomics and Diagnostics Kruppel-like factors research Cell death mechanisms and regulation RNA Interference and Gene Delivery

Related Journals

BC
Breast Cancer Research BioMed Central
CT
Current Treatment Options in Oncology Springer Science+Business Media
AO
Archives of Pharmacal Research Springer Nature
EC
Experimental Cell Research Elsevier BV
JO
Journal of Chemotherapy Taylor & Francis
BC
Blood Cancer Journal Springer Nature